The CBMM Purpose
The CBM2 vision is to design, manufacture, and deliver new tools to the biomedical community that utilize liquid biopsies for disease detection and management — Precision Medicine.
Our mission is to make meaningful impact on people's well-being through the delivery of innovative and fully automated mixed-scale systems programmed for different disease states.
CBM2 is a multi-institutional Center (The University of Kansas, The University of Kansas Medical Center, Louisiana State University, Wake Forest Medical School, and The University of North Carolina-Chapel Hill), and is supported by the Biotechnology Resource Center mechanism from the National Institutes of Health (National Institute of Biomedical Imaging and Bioengineering; NIBIB).
